# The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

> **NCT01378533** · PHASE3 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** epirubicin, cyclophosphamide, paclitaxel, carboplatin, G-CSF

## Key facts

- **NCT ID:** NCT01378533
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01378533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01378533, "The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01378533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*